Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-07

FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for escitalopram oxalate from Aurobindo Pharma Limited, enabling this generic product to be marketed. This approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

SUPPL AP for ESCITALOPRAM (ESCITALOPRAM OXALATE)